Cargando…

Intravenous liposomal amphotericin B efficacy and safety for cutaneous and mucosal leishmaniasis: a systematic review and meta-analysis protocol

INTRODUCTION: Treatment of cutaneous and mucosal leishmaniasis (CL and ML, respectively) must be individualised as there is no universal therapeutic approach. Intravenous liposomal amphotericin B (L-AmB) is an accessible and relatively safe treatment that has been increasingly used for the treatment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Naeem, Faheel, Nathan, Keren, Chivinski, Jeffrey, Ekmekjian, Taline, Libman, Michael, Barkati, Sapha
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Infectious Diseases
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8211079/ https://www.ncbi.nlm.nih.gov/pubmed/34135039 http://dx.doi.org/10.1136/bmjopen-2020-045707

Ejemplares similares

Intravenous Liposomal Amphotericin B Efficacy and Safety for Cutaneous and Mucosal Leishmaniasis: A Systematic Review and Meta-analysis
por: Chivinski, Jeffrey, et al.
Publicado: (2023)

Strongyloides stercoralis prevalence in solid-organ and haematopoietic stem cell transplant candidates and recipients: a systematic review and meta-analysis protocol
por: Barkati, Sapha, et al.
Publicado: (2022)

Cutaneous leishmaniasis in a 12-year-old Syrian immigrant
por: Alghounaim, Mohammad, et al.
Publicado: (2022)

Disseminated tegumentary leishmaniasis refractory to liposomal amphotericin B treatment
por: Borges, Ana Flávia, et al.
Publicado: (2021)

Leishmaniose cutanée observée chez une jeune fille de 12 ans récemment immigrée de Syrie
por: Alghounaim, Mohammad, et al.
Publicado: (2022)

Treatment of Complex Cutaneous Leishmaniasis with Liposomal Amphotericin B
por: Ubals, Maria, et al.
Publicado: (2021)

Liposomal amphotericin B in travelers with cutaneous and muco-cutaneous leishmaniasis: Not a panacea
por: Guery, Romain, et al.
Publicado: (2017)

Self-reported depression and anxiety rates among females with cutaneous leishmaniasis in Hubuna, Saudi Arabia
por: Elfaki, Nahid, et al.
Publicado: (2023)

Cutaneous leishmaniasis in travellers and migrants: a 10-year case series in a Canadian reference centre for tropical diseases
por: Lemieux, Alexandre, et al.
Publicado: (2022)

Conventional Amphotericin B Associated Nephrotoxicity in Patients With Hematologic Malignancies
por: Gursoy, Vildan, et al.
Publicado: (2021)

Association between periorbital cutaneous leishmaniasis and basosquamous carcinoma
por: Grisolia, Danielle Santos, et al.
Publicado: (2021)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Liposomal Amphotericin B and Leishmaniasis: Dose and Response
por: Sundar, Shyam, et al.
Publicado: (2010)

962. Cutaneous Leishmaniasis: Investigating Skin Drug Levels to Optimize Liposomal Amphotericin Dosing
por: Aronson, Naomi E, et al.
Publicado: (2018)

Visceral Leishmaniasis in a Non-endemic Region of Eritrea
por: Alamin, Amin A
Publicado: (2020)

Rhinophyma-Like Cutaneous Leishmaniasis due to Leishmania aethiopica Treated Successfully with Liposomal Amphotericin B
por: Kirchberger, Michael Constantin, et al.
Publicado: (2019)

Failure of Liposomal-amphotericin B Treatment for New World Cutaneous Leishmaniasis due to Leishmania braziliensis
por: Kosaka, Atsushi, et al.
Publicado: (2020)

Formulation of Amphotericin B in PEGylated Liposomes for Improved Treatment of Cutaneous Leishmaniasis by Parenteral and Oral Routes
por: Ramos, Guilherme S., et al.
Publicado: (2022)

Liposomal amphotericin B as a treatment for human leishmaniasis
por: Balasegaram, Manica, et al.
Publicado: (2012)

Visceral leishmaniasis-associated mortality in Bangladesh: a retrospective cross-sectional study
por: Huda, M Mamun, et al.
Publicado: (2014)

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
por: Layegh, Pouran, et al.
Publicado: (2011)

Leishmaniasis in Cameroon: what is known and is done so far? A protocol for systematic review
por: Djune Yemeli, Linda, et al.
Publicado: (2021)

Antimony to Cure Visceral Leishmaniasis Unresponsive to Liposomal Amphotericin B
por: Morizot, Gloria, et al.
Publicado: (2016)

Community IntraVenous Antibiotic Study (CIVAS): protocol for an evaluation of patient preferences for and cost-effectiveness of community intravenous antibiotic services
por: Czoski Murray, C, et al.
Publicado: (2015)

Prognostic prediction models for clinical outcomes in patients diagnosed with visceral leishmaniasis: protocol for a systematic review
por: Wilson, James, et al.
Publicado: (2023)

Comparative efficacy, toxicity and biodistribution of the liposomal amphotericin B formulations Fungisome(®) and AmBisome(®) in murine cutaneous leishmaniasis
por: Wijnant, Gert-Jan, et al.
Publicado: (2018)

Local Skin Inflammation in Cutaneous Leishmaniasis as a Source of Variable Pharmacokinetics and Therapeutic Efficacy of Liposomal Amphotericin B
por: Wijnant, Gert-Jan, et al.
Publicado: (2018)

American cutaneous leishmaniasis in French Guiana: a retrospective comparison between liposomal amphotericin B and meglumine antimoniate
por: Senchyna, A., et al.
Publicado: (2020)

Efficacy of Intralesional Amphotericin B for the Treatment of Cutaneous Leishmaniasis
por: Goyonlo, Vahid Mashayekhi, et al.
Publicado: (2014)

Treatment of mucosal leishmaniasis with amphotericin B lipid complex (ABLC)
por: Tuon, Felipe Francisco, et al.
Publicado: (2018)

Primary Cutaneous Nocardiosis: A Rare Presentation of Nocardiosis
por: Tariq, Ezza Fatima, et al.
Publicado: (2019)

An Unusual Case of the Successful Treatment of Carbapenem-resistant Ventriculitis with Intravenous Colistin
por: Abu Bakar, Azizi, et al.
Publicado: (2020)

Necrotizing Fasciitis Due to Prevotella denticola Infection in an Intravenous Drug User
por: Ling, Jeremiah, et al.
Publicado: (2022)

Clinical features, immunological interactions and household determinants of visceral leishmaniasis and malaria coinfections in West Pokot, Kenya: protocol for an observational study
por: van Dijk, Norbert, et al.
Publicado: (2023)

Purpura Fulminans: A Cutaneous Marker of Disseminated Intravascular Coagulation
por: Ghosh, Sudip Kumar, et al.
Publicado: (2009)

Clostridium Tetani Bacteremia From a Suspected Cutaneous Source
por: Kazadi, David, et al.
Publicado: (2022)

Assessment of the knowledge, attitude, and practice related to visceral leishmaniasis among residents of Al-Suwaira city, Wasit Governorate, Middle East of Iraq
por: Kanaan, Manal Hadi Ghaffoori, et al.
Publicado: (2022)

Comparative study on liposomal amphotericin B and other therapies in the treatment of mucosal leishmaniasis: A 15-year retrospective cohort study
por: Santos, Carolina Rocio, et al.
Publicado: (2019)

Borrelia burgdorferi sensu lato seroconversion after intravenous immunoglobulin treatment: A cohort study
por: Lucke, Ilse M., et al.
Publicado: (2021)

Epidemiological and clinical characteristics of cutaneous leishmaniasis among patients attending at Tefera Hailu Memorial Hospital, Sekota, Northeast Ethiopia: A five-year trend analysis (2016–2020)
por: Debash, Habtu, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_353aolg4nln2jhpokna1fqp045